Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine‐needle aspirates: A quality‐assurance metric for evaluating diagnostic performance in a cytopathology laboratory
Keyword(s):
2017 ◽
Vol 6
(5)
◽
pp. S74
2015 ◽
Vol 2
(1)
◽
pp. e000075
◽
2015 ◽
Vol 143
(2)
◽
pp. 193-200
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):